Ignite Creation Date:
2024-05-06 @ 7:37 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06073132
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2023-09-12
Brief Title:
An International Multicenter Randomized Double-Blind Parallel Group Vehicle-Controlled Phase 23 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1 Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex EBS
Sponsor:
TWi Biotechnology Inc
Organization:
TWi Biotechnology Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-04
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-12
First Submit QC Date:
October 3 2023
Study First Post Date:
2023-10-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-10
Last Update Post Date:
2024-07-11
Last Update Post Date Type:
ACTUAL